Course Description
Activity Dates: 01/01/2026 - 12/31/2027
This BCPP prep product includes 11 recorded review webinars and one "last-chance" question and answer session with authors/presenters.
Question and Answer Session: The live, last chance Q&A conference call will be scheduled in the spring and fall. The conference call will allow participants the opportunity to ask questions of the Review Course editors.
Webinars: The recorded webinar presentations are structured to provide a review of the major topics in the psychiatric pharmacy domains as specified by the BCPP Specialty Council in the current edition of the BPS Candidate's Guide. Webinars feature case-based self-assessment questions with feedback. To obtain optimal benefit, the participant should also purchase the Psychiatric Pharmacotherapy Review Book (check out the bundle cost savings) and have reviewed the chapter for the specified disease state before listening to the recorded presentation. The presenter will be referring the participant back to the chapter for complete details on some items.
To maintain its strict, independent standards for certification, BPS does NOT develop, endorse, or support review information, preparatory courses, or study guides.
Target Audience
This activity has been developed and designed for pharmacists who are preparing to sit for the Board of Pharmacy Specialty (BPS) exam in Psychiatric Pharmacy as they strive to obtain the credentials of Board Certified Psychiatric Pharmacist (BCPP).
Faculty
View biographical information
Kevin Bozymski, PharmD, BCPS, BCPP
Associate Professor, Department of Clinical Sciences (School of Pharmacy)
Associate Professor, Department of Psychiatry & Behavioral Medicine (School of Medicine)
Medical College of Wisconsin
Milwaukee, Wisconsin
No Relevant Financial Relationships to Disclose
Ryan Carnahan, PharmD, MS, BCPP
Professor and Director of Graduate Studies
Department of Epidemiology
The University of Iowa College of Public Health
Iowa City, Iowa
No Relevant Financial Relationships to Disclose
Melissa Cloyd, PharmD, BCPP, BCGP, BCPS, DPLA
Assistant Director of Pharmacy
Riverside University Health System – Medical Center
Moreno Valley, CA
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Neurocrine Speakers Bureau - Ingrezza
Clayton English, PharmD, BCPS, BCPP, BCGP, FAAPP
Assistant Professor, Department of Pharmacy
University of Washington School of Pharmacy
Seattle, WA
Educational Grants, Research Grants or Contracts: Garvey Institute for Brain Health Solutions (Philanthropic), Research Grant
Megan Ehret, PharmD, MS, BCPP, FAAPP
Professor of Practice, Sciences, and Health Outcomes Research
University of Maryland School of Pharmacy
Baltimore, MD
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Saladex Biomedical Consultant, Lexi-Comp Consultant/Reviewer
Educational Grants, Research Grants or Contracts: FDA/University of Maryland CERSI, Maryland Behavioral Health Department, NIH
Sarah Grady, PharmD, BCPP, BCPS
Professor of Pharmacy Practice
Drake University College of Pharmacy & Health Sciences
Des Moines, Iowa
No Relevant Financial Relationships to Disclose
My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices: lithium, buspirone, lamotrigine
Daniel Greer, PharmD, BCPP
Clinical Assistant Professor
Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey
Piscataway, NJ
No Relevant Financial Relationships to Disclose
Robin Hieber, PharmD, BCPP
Clinical Pharmacy Program Manager and Clinical Pharmacist Practitioner, Mental Health
Veterans Integrated Service Network (VISN) 23, Veterans Health Administration
Minneapolis, MN
No Relevant Financial Relationships to Disclose
Jessa Koch, PharmD, BCPP, APh
Associate Clinical Professor, Loma Linda University School of Pharmacy
Assistant Professor, Loma Linda University School of Medicine, Department of Neurology
Loma Linda, CA
Educational Grants, Research Grants or Contracts: NACDS, HRSA
My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices: TBD and disclosed upon development of course content
Megan Maroney, PharmD, BCPP
Clinical Associate Professor
Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey
Piscataway, NJ
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Pharmacy Times - speaker and medical writing honoraria (ongoing), Novus Medical Education - consultant/medical writing (ongoing), Elsevier (ongoing),
My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices: amphetamines, cabergoline, carbidopa/levodopa, clomipramine, clonidine, corticosteroids, diphenhydramine, gabapentin, melatonin, methadone, methylphenidate, mirtazapine, oxycodone, pregabalin, quetiapine, selegiline, trazodone, valerian, venlafaxine, potentially others
Lindsey Miller, PharmD, BCPP
Associate Professor of Pharmacy Practice
Lipscomb University College of Pharmacy
Clinical Psychiatric Pharmacist
Vanderbilt Psychiatric Hospital
Nashville, TN
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Social Security Administration- Board of Adjudication: Presentations on various disease states
Financial Interests: Pharmacy Times Panel Discussant- Payer Forum Sponsored by Alkermes (January 2020), Pharmacy Times- CE Presentation Sponsored by Otsuka (August 2019)
My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices
Sandra Mitchell, PharmD, BCPP, FAAPP
Clinical Pharmacy Specialist – Psychiatry
VCU Health
Clinical Affiliate Associate Professor, Virginia Commonwealth University School of Pharmacy
Richmond, Virginia
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Wolters Kluwer Consultant
My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or device: ADHD-bupropioin, modafinil; ASD-haloperidol, fluphenazine, chlorpromazine, divalproex, N-acetylcysteine, amantadine, melatonin, omega-3 fatty acids, probiotics, zinc; Tics-risperidone, tiapride, sulpride, clonidine, guanfacine, olanzapine, quetiapine, ziprasidone, fluphenazine, botulinum toxin, metoclopramide, baclofen, levetiraacetam, IVIG, NAC, nicotine, riluzole, d-serine, ondansetorn, pramipexole, methylphenidate, desipramine; ODD/CD-antipsychotics, stimulants, Klinefelter's-ZYN002
Jill Nofziger, PharmD, BCPS, BCPP
Ambulatory Care Pharmacy Supervisor
Kaiser Permanente Northern California
Oakland, CA
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: ACSAP 2023 Book 2 (Geriatric and Pediatric Care) - chapter expert reviewer, Stanford University Masters of Science Physician Assistant Program - lecturer for depression, anxiety, bipolar, and schizophrenia modules, CSHP Advanced Pharmacist Practitioner (APP) Certificate Program - 8 hour ACPE-accredited CE- presenter & case facilitator
My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices: Oxcarbazepine, Clozapine
Carol Ott, PharmD, MPH, BCPP, FAAPP
Clinical Professor, Pharmacy Practice
Purdue University College of Pharmacy
West Lafayette, IN
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Project ECHO - Indiana University - Opioid Use Disorders - Expert Panelist, Tippecanoe County (Indiana) Public Defender's Office - case consultation, Psychopharmacology Consultation Team - Indiana University - Department of Child Services, Wolters-Kluwer/Lexi-Comp
Non-Financial Interests: Indiana Medicaid Drug Utilization Review (DUR) Board, Indiana Medicaid Mental Health Quality Advisory Committee (MHQAC), NAMI West Central Indiana, Tippecanoe County, Indiana, Board of Health
Chris Paxos, PharmD, BCPP, BCPS, BCGP
Professor, Pharmacy Practice
Northeast Ohio Medical University
Rootstown, OH
No Relevant Financial Relationships to Disclose
Stephanie Vail, PharmD, MPH, BCPP, FCCP, FAAPP
Professor, Pharmacy Practice
University of New England
Portland, ME
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: I am a member of the New England Public Advisory Council (affiliated with the Institute for Clinical and Economic Review), I am a consultant for SAMHSA grant funded Opioid Response Network.
Educational Grants, Research Grants or Contracts: I am contracted as a subject matter expert for multiple Project ECHO communities in Northern New England that focus on OUD, AUD, and psychiatric conditions in older adults. These are hosted by the University of New Hampshire system; I am contracted as a SME for the Support for ME (Maine) SUD grant funded provider education and support program
Non-Financial Interests: Maine Independent Clinical Information Service Academic Detailing Advisory Committee, Member of the Maine's Gubernatorial Opioid Response Clinical Advisory Committee, Member of the Lunder-Dineen Time to Ask (about unhealthy drinking) Advisory Committee, Member of the Board of Directors of the Co-Occurring Collaborative Serving Maine, Member of the Maine Medical Professionals Health Program Advisory Committee, Chair of the Maine Prescription Monitoring Program Advisory Committee
Carolanne Wartman, PharmD, BCPS, BCPP
Assistant Clinical Professor
University of Arizona College of Pharmacy
Tucson, AZ
Educational Grants, Research Grants or Contracts: Office of National Drug Control Policy of the Executive Office of the President of the United States of America
My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or device: May discuss general off-label use (ex: BZDs not approved for alcohol withdrawal but still used)
Continuing Education Credit and Disclosures
Activity Dates: 01/01/2026 - 12/31/2027
There is no ACPE or BCPP Recertification credit available for this course.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View planning committee disclosures
Editorial Board
Professor of Practice, Sciences, and Health Outcomes Research
University of Maryland School of Pharmacy
Baltimore, MD
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Saladex Biomedical Consultant, Lexi-Comp Consultant/Reviewer
Educational Grants, Research Grants or Contracts: FDA/University of Maryland CERSI, Maryland Behavioral Health Department, NIH
Clinical Professor, Pharmacy Practice
Purdue University College of Pharmacy
West Lafayette, IN
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Project ECHO - Indiana University - Opioid Use Disorders - Expert Panelist, Tippecanoe County (Indiana) Public Defender's Office - case consultation, Psychopharmacology Consultation Team - Indiana University - Department of Child Services, Wolters-Kluwer/Lexi-Comp
Non-Financial Interests: Indiana Medicaid Drug Utilization Review (DUR) Board, Indiana Medicaid Mental Health Quality Advisory Committee (MHQAC), NAMI West Central Indiana, Tippecanoe County, Indiana, Board of Health
Professor, Pharmacy Practice
University of New England
Portland, ME
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: I am a member of the New England Public Advisory Council (affiliated with the Institute for Clinical and Economic Review), I am a consultant for SAMHSA grant funded Opioid Response Network.
Educational Grants, Research Grants or Contracts: I am contracted as a subject matter expert for multiple Project ECHO communities in Northern New England that focus on OUD, AUD, and psychiatric conditions in older adults. These are hosted by the University of New Hampshire system; I am contracted as a SME for the Support for ME (Maine) SUD grant funded provider education and support program
Non-Financial Interests: Maine Independent Clinical Information Service Academic Detailing Advisory Committee, Member of the Maine's Gubernatorial Opioid Response Clinical Advisory Committee, Member of the Lunder-Dineen Time to Ask (about unhealthy drinking) Advisory Committee, Member of the Board of Directors of the Co-Occurring Collaborative Serving Maine, Member of the Maine Medical Professionals Health Program Advisory Committee, Chair of the Maine Prescription Monitoring Program Advisory Committee
All relevant relationships have been mitigated.